SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-Nov-21 9:05 AM View: | Acceleron Pharma Inc (XLRN) | 19-Nov-21 | Disposition (change in control) | 23,423 | -- | -- | (100%) 23.42K to 0 | |
12-Nov-21 4:15 PM View: | Acceleron Pharma Inc (XLRN) | 09-Nov-21 | Option Exercise | 4,500 | $29.37 | $132,165.00 | 24% 18.92K to 23.42K | |
22-Sep-21 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 21-Sep-21 | Option Exercise | 6,650 | $32.58 | $216,624.00 | 35% 18.92K to 25.57K | |
22-Sep-21 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 21-Sep-21 | Market Option Sale (Planned) | 6,650 | $150.05 | $997,832.00 | (26%) 25.57K to 18.92K | (20%) |
09-Sep-21 5:07 PM View: | Acceleron Pharma Inc (XLRN) | 09-Sep-21 | Market Sale (Planned) | 1,407 | $130.00 | $182,910.00 | (7%) 20.33K to 18.92K | (38%) |
09-Sep-21 5:07 PM View: | Acceleron Pharma Inc (XLRN) | 08-Sep-21 | Market Sale (Planned) | 6 | $130.00 | $780.00 | (< 1%) 20.34K to 20.33K | (38%) |
09-Sep-21 5:07 PM View: | Acceleron Pharma Inc (XLRN) | 07-Sep-21 | Payment of Exercise | 587 | $129.36 | $75,934.30 | (3%) 20.92K to 20.34K | (39%) |
08-Jun-21 6:53 PM View: | Acceleron Pharma Inc (XLRN) | 07-Jun-21 | Payment of Exercise | 108 | $126.69 | $13,682.50 | (< 1%) 21.03K to 20.92K | (42%) |
02-Feb-21 7:50 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jan-21 | Grant | 4,868 | -- | -- | 30% 16.16K to 21.03K | |
06-Jan-21 7:12 PM View: | Acceleron Pharma Inc (XLRN) | 05-Jan-21 | Market Sale (Planned) | 2,056 | $122.56 | $251,988.00 | (11%) 18.22K to 16.16K | (47%) |
06-Jan-21 7:12 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-21 | Payment of Exercise | 942 | $124.31 | $117,100.00 | (5%) 19.16K to 18.22K | (45%) |
09-Sep-20 5:49 PM View: | Acceleron Pharma Inc (XLRN) | 08-Sep-20 | Market Sale (Planned) | 2,000 | $89.50 | $179,004.00 | (9%) 21.16K to 19.16K | (101%) |
10-Apr-20 5:30 PM View: | Acceleron Pharma Inc (XLRN) | 08-Apr-20 | Option Exercise | 6,000 | $27.97 | $167,820.00 | 28% 21.16K to 27.16K | |
10-Apr-20 5:30 PM View: | Acceleron Pharma Inc (XLRN) | 08-Apr-20 | Market Option Sale (Planned) | 6,000 | $85.58 | $513,509.00 | (22%) 27.16K to 21.16K | (110%) |
24-Jan-20 5:33 PM View: | Acceleron Pharma Inc (XLRN) | 22-Jan-20 | Grant | 6,369 | -- | -- | 43% 14.79K to 21.16K | |
03-Jan-20 9:51 PM View: | Acceleron Pharma Inc (XLRN) | 03-Jan-20 | Market Sale (Planned) | 875 | $51.23 | $44,826.20 | (6%) 15.67K to 14.79K | (251%) |
03-Jan-20 9:51 PM View: | Acceleron Pharma Inc (XLRN) | 02-Jan-20 | Market Sale (Planned) | 434 | $52.83 | $22,928.20 | (3%) 16.1K to 15.67K | (240%) |
10-Sep-19 8:25 PM View: | Acceleron Pharma Inc (XLRN) | 10-Sep-19 | Market Sale (Planned) | 824 | $45.20 | $37,241.40 | (5%) 16.93K to 16.1K | (298%) |
12-Aug-19 4:18 PM View: | Acceleron Pharma Inc (XLRN) | 09-Aug-19 | Market Sale (Planned) | 3,268 | $45.00 | $147,060.00 | (16%) 20.19K to 16.93K | (299%) |
17-Jul-19 5:49 PM View: | Acceleron Pharma Inc (XLRN) | 16-Jul-19 | Market Sale (Planned) | 538 | $40.71 | $21,902.00 | (3%) 20.73K to 20.19K | (341%) |
07-Jun-19 4:39 PM View: | Acceleron Pharma Inc (XLRN) | 05-Jun-19 | Grant | 1,100 | -- | -- | 6% 19.63K to 20.73K |